Anti-TNFRSF18/GITR/CD357 Antibody (Ragifilimab)
Catalog No.
F1063
Anti-TNFRSF18/GITR/CD357 Antibody (Ragifilimab)
Featured Products
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used in advanced or metastatic solid tumors.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.46 kDa
Dry ice
2207590-51-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
INCAGN1876, INCAGN01876, AGEN1876
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9Y5U5
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF18 / GITR / CD357
Please avoid freeze-thaw cycles.